Author(s): Dinan TG, Stanton C, Cryan JF
Abstract Share this page
Abstract Here, we define a psychobiotic as a live organism that, when ingested in adequate amounts, produces a health benefit in patients suffering from psychiatric illness. As a class of probiotic, these bacteria are capable of producing and delivering neuroactive substances such as gamma-aminobutyric acid and serotonin, which act on the brain-gut axis. Preclinical evaluation in rodents suggests that certain psychobiotics possess antidepressant or anxiolytic activity. Effects may be mediated via the vagus nerve, spinal cord, or neuroendocrine systems. So far, psychobiotics have been most extensively studied in a liaison psychiatric setting in patients with irritable bowel syndrome, where positive benefits have been reported for a number of organisms including Bifidobacterium infantis. Evidence is emerging of benefits in alleviating symptoms of depression and in chronic fatigue syndrome. Such benefits may be related to the anti-inflammatory actions of certain psychobiotics and a capacity to reduce hypothalamic-pituitary-adrenal axis activity. Results from large scale placebo-controlled studies are awaited. © 2013 Society of Biological Psychiatry.
This article was published in Biol Psychiatry
and referenced in Abnormal and Behavioural Psychology
- Michelle Jimenez
Can Pre-treatment Motivational Groups in FATJAM Promote Therapeutically-Relevant Changes for Juvenile Fire Setters and Bomb Makers in a Forensic Psychological Setting?
PPT Version | PDF Version